ETON - Eton Pharmaceuticals GAAP EPS of $0.18 revenue of $12M August, 10 2023 04:42 PM Eton Pharmaceutcials Inc. 2023-08-10 16:42:06 ET Eton Pharmaceuticals press release ( NASDAQ: ETON ): Q2 GAAP EPS of $0.18. Revenue of $12M (+62.2% Y/Y). For further details see: Eton Pharmaceuticals GAAP EPS of $0.18, revenue of $12M